Medical Research Council Biomedical Catalyst: Development Pathway Funding Scheme
Deadline for applications: 25th March 2020
The scheme supports academically led projects whose goals are to improve prevention, diagnosis, prognosis, or treatment of significant health needs, or that focus on developing research tools that increase the efficiency of developing interventions.
The following activities are eligible for support:
- Developing candidate therapeutic entities (e.g. drug discovery)
- Pre-clinical testing of novel therapeutic entities
- Early-phase clinical studies of novel therapeutic entities (phases 1 and 2)
- “Repurposing” clinical studies – using existing therapies for new indications
- Developing and testing novel devices
- Developing and testing diagnostics (including biomarker validation)
Click here for more information